Search results for " therapeutic"
Article
Setting Standards for Biotech Therapeutics in India
…O) together with the State Authorities are primarily responsible for ensuring the quality of biotech therapeutics post-approval. The Indian Pharmacopoeia Commission (IPC), which creates and publishes…
Article
Virus-like Particles as Therapeutic Moieties of the Future
In this 44th article in the “Elements of Biopharmaceutical Production” series, the authors review the status of VLPs as therapeutics as well as challenges associated with their analytical and function…
Article
Techniques for Improving Process Development for Exosome-Derived Therapeutics
These nano-scale membrane sacs are mediators of intercellular communication and can be exploited as carriers of therapeutic molecules (like proteins and RNA) that can alter disease states.
…
Article
The Need for Advanced Process Modeling for New Therapeutic Biologics
The trend toward personalized medicines includes more complex manufacturing cycles that can benefit from advanced process modeling early on in the therapeutics’ development.
By Feli…
Article
Modeling the Degradation of mAb Therapeutics
Proteins pose stability risks
Monoclonal antibodies are currently the leading class of protein therapeutic molecules due to their ability to treat a wide range of lethal and life-threatening disea…
Article
Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions
There is also a significant requirement for therapeutic vaccines to treat existing and prevent further chronic viral infections. As a result, there is an urgent need to develop alternative vaccine pro…
Article
Developing oligonucleotide therapeutics with confidence
You will learn about:
• the oligonucleotide therapeutic market
• the therapeutics in development
• challenges you may face and key considerations to address those challenges
• how to …
Article
How can you harness the potential of nucleic acid therapeutics?
At Cytiva, the new team is here to support you. We can help you throughout the
development of your manufacturing workflow for oligonucleotides
and the purification of mRNA drug subs…
Article
Advanced therapeutics process development using mechanistic modeling
Guterstam
Watch the interview of Peter Guterstam and Nick Whitelock (Cytiva), and learn about
the biological background of advanced therapeutics
what mechanistic modelling …
Article
Defining Critical Quality Attributes for Monoclonal Antibody Therapeutic Products
Biotech therapeutics, particularly complex products such as monoclonal antibodies (mAbs), can have numerous quality attributes that can potentially impact safety and/or efficacy of the product (2). Id…